Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Apr;66(4):631-3.

In vivo treatment with an appropriate anti-Thy-1.2 monoclonal antibody abrogates hybrid resistance to Thy-1.1+ virus-immune effector T cells

P C Doherty  1 , J E Allan, W Allan
Affiliations

In vivo treatment with an appropriate anti-Thy-1.2 monoclonal antibody abrogates hybrid resistance to Thy-1.1+ virus-immune effector T cells

P C Doherty et al. Immunology. 1989 Apr.

Abstract

The hybrid resistance (Hr) effect operates to limit the induction of T-cell-mediated inflammatory processes following transfer into recipients injected with murine lymphocytic choriomeningitis virus (LCMV). Adoptively transferred Thy-1.1+ H-2b (KbDb) LCM virus-immune T cells are inhibited in cyclophosphamide (Cy)-suppressed, virus-infected mice that are heterozygous for H-2Db (e.g. H-2k x b F1). Injection of recipient animals with monoclonal antibody (mAb) to Thy-1.2 resulted in the elimination of Thy-1.2+ H-2b x d F1 effectors on transfer to H-2b x d F1 recipients. The Hr effect was removed by mAb treatment of Thy-1.2+ F1 recipients given H-2b Thy-1.1+-immune T cells. Apparently Hr is mediated by a cell which is Thy-1+.

PubMed Disclaimer

References

    1. Clin Exp Immunol. 1975 Feb;19(2):355-66 - PubMed
    1. Immunology. 1988 Mar;63(3):423-9 - PubMed
    1. Immunol Rev. 1979;47:63-90 - PubMed
    1. J Immunol. 1980 Dec;125(6):2665-72 - PubMed
    1. Immunol Rev. 1983;71:31-56 - PubMed

LinkOut - more resources